Evidence map›Paper›PMID 34187480›Full record

ArticleJournal of inflammation (London, England)2021

Increased levels of S100A8/A9, IL-1ß and IL-18 as a novel biomarker for recurrent tonsillitis.

Christoph Spiekermann, Alicia Seethaler, Annika McNally, Markus Stenner, Claudia Rudack, Johannes Roth, Thomas Vogl

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christoph SpiekermannInstitute of Immunology, University Hospital Münster, Münster, Germany. christophOtto.Spiekermann@ukmuenster.de.ORCID http://orcid.org/0000-0002-0775-2788
Alicia SeethalerDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Münster, Kardinal-von-Galen-Ring 10, 48149, Münster, Germany.
Annika McNallyInstitute of Immunology, University Hospital Münster, Münster, Germany.
Markus StennerDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Münster, Kardinal-von-Galen-Ring 10, 48149, Münster, Germany.
Claudia RudackDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Münster, Kardinal-von-Galen-Ring 10, 48149, Münster, Germany.
Johannes RothInstitute of Immunology, University Hospital Münster, Münster, Germany.
Thomas VoglInstitute of Immunology, University Hospital Münster, Münster, Germany.
University Hospital Münster · DE

Funding

Bundesministerium für Bildung und Forschung AID-NETDeutsche Forschungsgemeinschaft CRC 1009 B8Deutsche Forschungsgemeinschaft CRC 1009 B9Medizinische Fakultät, Westfälische Wilhelms-Universität Münster Ro2/023/19Medizinische Fakultät, Westfälische Wilhelms-Universität Münster SP 2 1 15 11Medizinische Fakultät, Westfälische Wilhelms-Universität Münster Vo2/011/19
6 · The paper itself

Abstract

backgroundAcute tonsillitis represents one of the most frequent reasons patients seek primary medical care and otorhinolaryngology consultation. Therefore, recurrent episodes of acute tonsillitis (RAT), also called chronic tonsillitis, exhaust a substantial amount of medical and financial resources. Diagnosis of tonsillitis depends on a physical examination, which therefore does not allow for a reliable differentiation between viral and bacterial infection. However, the frequency of bacterial infections during the previous three years is currently being used as the major deciding factor in patient selection for tonsillectomy. The aim of the present study was to determine an objective biomarker to help in the identification of patients suffering from recurrent tonsillitis.

resultsBy analyzing a panel of cytokines and chemokines in serum and saliva of patients with RAT compared to healthy controls, increased levels of IL-1ß (153.7 ± 48.5 pg/ml vs 23.3 ± 6.6 pg/ml, p = 0.021), IL-18 (120.2 ± 16.5 vs 50.6 ± 9.3 pg/ml, p = 0.007) and/or S100A8/A9 (996 ± 102 ng/ml vs 546 ± 86 ng/ml, p = 0.042) could be observed in patients suffering from RAT. Cut-off values of these parameters were determined and combined to a new RAT-score allowing for reliable identification of patients suffering from recurrent tonsillitis with a sensitivity of 95% and a specificity of 88%.

conclusionThe RAT-score represents the first objective criterion as a tool for the diagnosis of recurrent tonsillitis and it also improves patient selection for tonsillectomy.

Indexed as

BiomarkerCalprotectinDiagnosisInterleukinRecurrent tonsillitis

Identifiers

PMID34187480
PMCPMC8243502
OpenAlexW3174240229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.